#Japan #Tokyo #Biopharma #Xtalks

Webinar Overview

In today’s pharmaceutical landscape, Japan stands out as a unique market with both immense potential and significant complexity. As the world’s third-largest pharmaceutical market, it offers lucrative opportunities for global biopharma companies. However, entering this market requires a nuanced understanding of its pricing and reimbursement intricacies. This is where the upcoming free webinar, The ART of Market Entry, hosted by Xtalks, steps in to provide a comprehensive guide.

What You Will Learn

The webinar focuses on how to maximize asset value within Japan’s distinct pricing and reimbursement framework. Attendees can expect insights into the following key areas:

1. Understanding Pricing Calculation Methods: The webinar will delve into how pricing is calculated in Japan and the various reimbursement pathways available for pharmaceutical products. This knowledge is crucial for any industry stakeholder looking to navigate market entry successfully.

2. Crafting a Value Proposition: It’s not just about getting your foot in the door; it’s about conveying a compelling story that highlights the value of your product. You'll learn how to tailor your product’s value proposition to align with Japan’s market needs effectively.

3. Optimal Go-to-Market Strategies: Recognizing that one size doesn't fit all, the experts will discuss various go-to-market models tailored to Japan. From full in-market builds to hybrid and out-licensing models, you’ll understand when and how to deploy these strategies effectively.

4. Navigating Required Milestones for MAH Designation: Acquiring Market Authorization Holder (MAH) designation is essential for market entry. The webinar will guide you through the minimum requirements and important steps to achieve MAH status.

5. Timelines for Launch Success: Time is often a critical factor in launching a product. Attendees will get insights into an optimal timeline that includes essential milestones such as clinical trials, PMDA (Pharmaceuticals and Medical Devices Agency) approval, MAH filing, and reimbursement strategy—all necessary for achieving launch readiness.

Why Attend?

With a panel of experts from Syneos Health, this webinar promises to unravel the complexities of Japan's pharmaceutical market through the ART framework: Asset, Resource, and Timeline. By unpacking the regulatory steps, hiring considerations, and pricing levers needed for successful market entry, attendees can expect practical, real-world insights grounded in extensive consulting experience.

Target Audience

This session is tailored for industry professionals interested in expanding their products into Japan. Whether you're considering a full-scale investment or contemplating a hybrid approach, this webinar will offer valuable insights to guide your decisions.

Featured Speakers

1. Yunke Song, PhD - Managing Director, Consulting, Japan, Syneos Health
2. Adam Kennedy - Vice President, TSP APAC, Syneos Health
3. Pascal Rigaudy - Former Executive at Sanofi

Event Details

• - Date: Thursday, March 5, 2026
• - Time: 11 AM EST (5 PM CET/EU-Central)

Registration Information

To ensure your spot in this informative session, please register in advance. For more details and to register, visit The ART of Market Entry and turn the uncertainties of entering the Japanese market into opportunities for success.

About Xtalks: Xtalks is a pioneering platform for professionals across the pharmaceutical, biotech, and healthcare industries. With an extensive array of resources—including webinars, articles, and expert interviews—Xtalks empowers industry leaders to stay informed and prepared in a rapidly evolving marketplace.

Join us for an invaluable session that could define your strategy for biopharma success in Japan!